Clinical Significance of an Increased Cochlear 3D Fluid-Attenuated Inversion Recovery Signal Intensity on an MR Imaging Examination in Patients with Acoustic Neuroma

REFERENCES

1. 1.↵
   1. Bhadelia RA,
   2. Tedesco KL,
   3. Hwang S,
   4. et al

   . Increased cochlear fluid-attenuated inversion recovery signal in patients with vestibular schwannoma. AJNR Am J Neuroradiol 2008;29:720–23

   Abstract/FREE Full Text
2. 2.↵
   1. Lee IH,
   2. Kim HJ,
   3. Chung WH,
   4. et al

   . Signal intensity change of the labyrinth in patients with surgically confirmed or radiologically diagnosed vestibular schwannoma on isotropic 3D fluid-attenuated inversion recovery MR imaging at 3 T. Eur Radiol 2010;20:949–57

   CrossRefPubMed
3. 3.↵
   1. Sugiura M,
   2. Naganawa S,
   3. Nakata S,
   4. et al

   . 3D-FLAIR MRI findings in a patient with Ramsay Hunt syndrome. Acta Otolaryngol 2007;127:547–49

   CrossRefPubMed
4. 4.↵
   1. Sugiura M,
   2. Naganawa S,
   3. Sone M,
   4. et al

   . Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings in a patient with cochlear otosclerosis. Auris Nasus Larynx 2008;35:269–72

   CrossRefPubMed
5. 5.↵
   1. Yamazaki M,
   2. Naganawa S,
   3. Kawai H,
   4. et al

   . Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma. Neuroradiology 2009;51:855–63

   CrossRefPubMed
6. 6.↵
   1. Yoshida T,
   2. Sugiura M,
   3. Naganawa S,
   4. et al

   . Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings and prognosis in sudden sensorineural hearing loss. Laryngoscope 2008;118:1433–37

   CrossRefPubMedWeb of Science
7. 7.↵
   1. O'Connor AF,
   2. France MW,
   3. Morrison AW

   . Perilymph total protein levels associated with cerebellopontine angle lesions. Am J Otol 1981;2:193–95

   PubMed
8. 8.↵
   1. Palva T,
   2. Raunio V

   . Cerebrospinal fluid and acoustic neurinoma specific proteins in perilymph. Acta Otolaryngol 1982;93:201–03

   PubMed
9. 9.↵
   1. Rasmussen N,
   2. Bendtzen K,
   3. Thomsen J,
   4. Tos M

   . Antigenicity and protein content of perilymph in acoustic neuroma patients. Acta Otolaryngol 1984;97:502–08

   CrossRefPubMed
10. 10.↵
    1. Silverstein H

    . Labyrinthine tap as a diagnostic test for acoustic neurinoma. Otolaryngol Clin North Am 1973;6:229–44

    PubMed
11. 11.↵
    1. Silverstein H,
    2. Schuknecht HF

    . Biochemical studies of inner ear fluid in man: changes in otosclerosis, Meniere's disease, and acoustic neuroma. Arch Otolaryngol 1966;84:395–402

    CrossRefPubMed
12. 12.↵
    1. Thomsen J,
    2. Saxtrup O,
    3. Tos M

    . Quantitated determination of proteins in perilymph in patients with acoustic neuromas. ORL J Otorhinolaryngol Relat Spec 1982;44:61–65

    CrossRefPubMed
13. 13.↵
    1. Busse RF,
    2. Hariharan H,
    3. Vu A,
    4. et al

    . Fast spin echo sequences with very long echo trains: design of variable refocusing flip angle schedules and generation of clinical T2 contrast. Magn Reson Med 2006;55:1030–37

    CrossRefPubMed
14. 14.↵
    1. Chagla GH,
    2. Busse RF,
    3. Sydnor R,
    4. et al

    . Three-dimensional fluid attenuated inversion recovery imaging with isotropic resolution and nonselective adiabatic inversion provides improved three-dimensional visualization and cerebrospinal fluid suppression compared to two-dimensional flair at 3 Tesla. Invest Radiol 2008;43:547–51

    CrossRefPubMed
15. 15.↵
    1. Kallmes DF,
    2. Hui FK,
    3. Mugler JP

    . Suppression of cerebrospinal fluid and blood flow artifacts in FLAIR MR imaging with a single-slab three-dimensional pulse sequence: initial experience. Radiology 2001;221:251–55

    CrossRefPubMed
16. 16.↵
    1. Melhem ER,
    2. Jara H,
    3. Eustace S

    . Fluid-attenuated inversion recovery MR imaging: identification of protein concentration thresholds for CSF hyperintensity. AJR Am J Roentgenol 1997;169:859–62

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Mugler JP,
    2. Bao S,
    3. Mulkern RV,
    4. et al

    . Optimized single-slab three-dimensional spin-echo MR imaging of the brain. Radiology 2000;216:891–99

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Naganawa S,
    2. Koshikawa T,
    3. Nakamura T,
    4. et al

    . Comparison of flow artifacts between 2D-FLAIR and 3D-FLAIR sequences at 3 T. Eur Radiol 2004;14:1901–08

    PubMed
19. 19.↵
    1. Otake H,
    2. Sugiura M,
    3. Naganawa S,
    4. et al

    . 3D-FLAIR magnetic resonance imaging in the evaluation of mumps deafness. Int J Pediatr Otorhinolaryngol 2006;70:2115–17

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Sugiura M,
    2. Naganawa S,
    3. Sato E,
    4. et al

    . Visualization of a high protein concentration in the cochlea of a patient with a large endolymphatic duct and sac, using three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging. J Laryngol Otol 2006;120:1084–86

    PubMed
21. 21.↵
    1. Sugiura M,
    2. Naganawa S,
    3. Teranishi M,
    4. et al

    . Inner ear hemorrhage in systemic lupus erythematosus. Laryngoscope 2006;116:826–28

    CrossRefPubMedWeb of Science
22. 22.↵
    Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma): American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg 1995;113:179–80

    FREE Full Text
23. 23.↵
    1. O'Connor AF,
    2. Luxon LM,
    3. Shortman RC,
    4. et al

    . Electrophoretic separation and identification of perilymph proteins in cases of acoustic neuroma. Acta Otolaryngol 1982;93:195–200

    CrossRefPubMed